Income Statement (TTM)
Sigma Healthcare Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2021 06-30 |
2022 06-30 |
2023 06-30 |
2024 06-30 |
2025 06-30 |
|
|---|---|---|---|---|---|
| Revenue | 2,420 | 2,993 | 3,091 | 3,294 | 6,002 |
| Change (%) | 23.67 | 3.27 | 6.59 | 82.18 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 1,752 | 1,921 | 2,173 | 2,251 | 4,562 |
| Change (%) | 9.64 | 13.14 | 3.61 | 102.60 | |
| % of Revenue | 72.38 | 64.17 | 70.31 | 68.34 | 76.00 |
| Gross Operating Profit | 668 | 1,072 | 918 | 1,043 | 1,440 |
| Change (%) | 60.46 | -14.42 | 13.65 | 38.10 | |
| % of Revenue | 27.62 | 35.83 | 29.69 | 31.66 | 24.00 |
| SG&A | 738 | 498 | 489 | 490 | 671 |
| Change (%) | -32.53 | -1.78 | 0.27 | 36.87 | |
| % of Revenue | 30.49 | 16.63 | 15.82 | 14.88 | 11.18 |
| R&D | |||||
| Change (%) | |||||
| % of Revenue | |||||
| OpEx | 2,490 | 2,418 | 2,662 | 2,742 | 5,233 |
| Change (%) | -2.86 | 10.07 | 3.00 | 90.85 | |
| % of Revenue | 102.87 | 80.80 | 86.13 | 83.22 | 87.18 |
| Operating Income | -70 | 575 | 429 | 553 | 769 |
| Change (%) | -926.32 | -25.38 | 28.90 | 39.18 | |
| % of Revenue | -2.87 | 19.20 | 13.87 | 16.78 | 12.82 |
| Interest Expense | -37 | -39 | -54 | -64 | -92 |
| Change (%) | 6.22 | 36.79 | 19.70 | 42.83 | |
| % of Revenue | -1.53 | -1.31 | -1.74 | -1.95 | -1.53 |
| Net Income | -176 | 386 | 304 | 541 | 530 |
| Change (%) | -319.31 | -21.14 | 77.77 | -2.05 | |
| % of Revenue | -7.27 | 12.89 | 9.85 | 16.42 | 8.83 |
Source: Capital IQ
